Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.79B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.86 (market cap $6.04B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 2.3× Iovance Biotherapeutics Inc. Common Stock's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| CX | IOVA | |
|---|---|---|
Market Cap | $13.79B | $6.04B |
Volume | 3,993,982 | 14,805,993 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $14.82 |
52-Week Low | $9.12 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.79B | $5.97B |
Dividend Yield | 1.3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
